Dupont Capital Management Corp trimmed its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 50.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,900 shares of the medical equipment provider’s stock after selling 4,986 shares during the period. Dupont Capital Management Corp’s holdings in Masimo Corporation were worth $424,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. increased its stake in shares of Masimo Corporation by 7.5% during the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock worth $721,710,000 after purchasing an additional 550,995 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Masimo Corporation by 6.9% during the 2nd quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock worth $450,036,000 after purchasing an additional 318,060 shares in the last quarter. Acadian Asset Management LLC increased its stake in shares of Masimo Corporation by 28.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after purchasing an additional 392,410 shares in the last quarter. State Street Corp increased its stake in shares of Masimo Corporation by 10.4% during the 2nd quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after purchasing an additional 146,212 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in shares of Masimo Corporation by 3.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,113,113 shares of the medical equipment provider’s stock worth $101,494,000 after purchasing an additional 38,991 shares in the last quarter. 84.94% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/13/dupont-capital-management-corp-sells-4986-shares-of-masimo-corporation-masi.html.

Shares of Masimo Corporation (NASDAQ MASI) opened at $86.49 on Monday. The company has a market cap of $4,469.04, a P/E ratio of 33.14, a price-to-earnings-growth ratio of 2.91 and a beta of 0.75. Masimo Corporation has a 12 month low of $60.03 and a 12 month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last released its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.17. The firm had revenue of $193.69 million during the quarter, compared to analysts’ expectations of $189.01 million. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. Masimo Corporation’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.52 EPS. analysts predict that Masimo Corporation will post 2.96 EPS for the current year.

A number of research analysts have recently weighed in on the stock. Roth Capital raised their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a research note on Thursday, November 2nd. Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 target price (up from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Finally, BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Monday, August 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $97.17.

In other Masimo Corporation news, Director Sanford Fitch sold 11,000 shares of Masimo Corporation stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the transaction, the director now owns 72,249 shares in the company, valued at approximately $6,303,725.25. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Yongsam Lee sold 13,976 shares of Masimo Corporation stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $89.43, for a total transaction of $1,249,873.68. Following the completion of the transaction, the executive vice president now owns 74,000 shares in the company, valued at approximately $6,617,820. The disclosure for this sale can be found here. In the last quarter, insiders sold 39,976 shares of company stock worth $3,559,074. 13.10% of the stock is owned by company insiders.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.